We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BBSE3:BMFBOVESPABB Seguridade Participacoes SA Analysis

Data as of 2026-03-14 - not real-time

R$35.05

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

BB Seguridade (BBSE3) trades at a trailing P/E of 7.5, well below the industry average of 16.3, and offers a dividend yield of 14.9% with a payout ratio near 92%. The company generates robust cash flow, posting free cash flow of roughly R$6.86 bn and carries no debt, underpinning the high dividend sustainability. With a return on equity of 90% and gross margins above 98%, the fundamentals are exceptionally strong, yet revenue growth remains modest at 0.2%. Technicals show a neutral price trend, the 20‑day SMA (~34.53) sits just below the current price (35.05) and the MACD histogram is positive, indicating a slight bullish bias despite decreasing volume. Volatility over the last 30 days is high at 39%, but the stock’s beta is very low (0.16), suggesting limited market‑wide risk. Recent news confirms a 5% YoY profit increase in Q4 2025 and a record dividend payout, reinforcing the income appeal. However, management signals a more conservative outlook for 2026, with premium growth expected to range between –3% and +2%, which could temper earnings momentum. The DCF‑derived fair value of R$53.6 implies a substantial long‑term upside, while analyst price targets average around R$37.5, indicating a modest near‑term upside of about 7.7%. In sum, BBSE3 combines deep value pricing, exceptional dividend yield, and a solid balance sheet, but faces near‑term earnings conservatism and elevated short‑term volatility.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • High dividend yield and sustainable payout
  • Undervalued relative to DCF fair value
  • Technical bullish signal from MACD histogram

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Conservative earnings outlook for 2026
  • Elevated short‑term volatility
  • Strong cash generation supporting dividend

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant long‑term upside potential from DCF valuation
  • Robust balance sheet with zero debt
  • Consistently high ROE and cash flow supporting dividend growth

Key Metrics & Analysis

Financial Health

Revenue Growth0.20%
Profit Margin87.25%
P/E Ratio7.5
ROE89.81%
ROA27.60%
P/B Ratio6.6
Op. Cash FlowR$3.7B
Free Cash FlowR$6.9B
Industry P/E16.4

Technical Analysis

TrendNeutral
RSI50.1
SupportR$33.02
ResistanceR$39.30
MA 20R$34.53
MA 50R$35.69
MA 200R$34.44
MACDBullish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair ValueR$53.59
Target PriceR$37.75
Upside/Downside7.70%
GradeUndervalued
TypeValue
Dividend Yield14.87%

Risk Assessment

Beta0.16
Volatility38.99%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.